Risk Factors for Gastric Cancer-Associated Thrombotic Diseases in a Han Chinese Population

Table 1

Univariate analyses on gastric cancer patients complicated with thrombotic diseases.

Factors	Case group ()	Control group ()	value	value
Patient-related factors
Gender			1.047	0.306
Male	52 (76.47%)	186 (70.19%)
Female	16 (23.53%)	79 (29.81%)
Age			4.144	0.042
<60	21 (30.88%)	118 (44.53%)
≥60	47 (69.12%)	147 (55.47%)
Smoking			0.790	0.374
Yes	29 (42.65%)	129 (48.68%)
No	39 (57.35%)	136 (51.32%)
Drinking			0.646	0.422
Yes	18 (26.47%)	58 (21.89%)
No	50 (73.53%)	207 (78.11%)
Diabetes			4.652	0.031
Yes	8 (11.76%)	63 (23.77%)
No	60 (88.24%)	202 (76.23%)
Hypertension			3.979	0.046
Yes	19 (27.94%)	109 (41.13%)
No	49 (72.06%)	156 (58.87%)
Anemia			0.005	0.945
Yes	27 (39.71%)	104 (39.25%)
No	41 (60.29%)	161 (60.75%)
Cancer-related factors
Histology			4.238	0.040
Adenocarcinoma	50 (73.53%)	159 (60.00%)
Non-adenocarcinoma	8 (26.47%)	106 (40.00%)
Cancer site			4.780	0.189
Cardia and fundus	14 (20.59%)	54 (20.38%)
Corpus	19 (27.94%)	71 (26.79%)
Angle	12 (17.65%)	77 (29.06%)
Pylorus	23 (33.82%)	63 (23.77%)
Treatment-related factors
Surgery			4.482	0.034
Yes	33 (48.53%)	166 (62.64%)
No	35 (51.47%)	99 (37.36%)
Chemotherapy			4.069	0.044
Yes	29 (42.65%)	79 (29.81%)
No	39 (57.35%)	186 (70.19%)
Hormone			0.859	0.354
Yes	14 (20.59%)	69 (26.04%)
No	54 (79.41%)	196 (73.96%)
Transfusion			2.793	0.095
Yes	10 (14.71%)	64 (24.15%)
No	58 (85.29%)	201 (75.85%)
PICC			4.032	0.045
Yes	12 (17.65%)	79 (29.814%)
No	56 (82.35%)	186 (70.19%)